United States · FDA National Drug Code directory
Spikevax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80777-115_7966274d-0378-44c8-9075-1df2c27aae9a
- Product NDC
- 80777-115
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- COVID-19 Vaccine, mRNA
- Labeler
- Moderna US, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260817
- Source listing expiry
- 20271231
Source-listed ingredients
- CX-055611 — 25 ug/.25mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, PLASTIC in 1 CARTON (80777-115-80) / .25 mL in 1 SYRINGE, PLASTIC (80777-115-09) · 80777-115-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →